TDF in HIV-positive pregnant women does not impair infant growth
The use of tenofovir disoproxil fumarate (TDF) among pregnant women with HIV does not seem to be linked to infant transient rickets, growth impairment, or renal dysfunction, reports a recent Vietnam study.